Utilizing national patient-register data to control for comorbidity in prognostic studies

Clinical Epidemiology

Volumn 6, Issue , 2014, Pages 395-404

  Nilssen, Yngvar ^a   Strand, Trond Eirik ^a   Wiik, Robert ^b   Bakken, Inger Johanne ^c   Yu, Xue Qin ^d,e   O’Connell, Dianne L ^d,e,f,g   Møller, Bjørn ^a  

^a Department of Registration Cancer Registry of Norway ^*  (Norway)

^b Norwegian Directorate of Health   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d CANCER RESEARCH DIVISION   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Charlson comorbidity index; Comorbidity; National patient register; Patient register index; Predictive ability; Prognostic value

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASSESSMENT OF HUMANS; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHILD; CHRONIC LUNG DISEASE; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MORTALITY; NEWBORN; NORWEGIAN (PEOPLE); PATIENT REGISTER INDEX; POPULATION RESEARCH; PRESCHOOL CHILD; PROGNOSIS; REGISTER; SCHOOL CHILD; SEX RATIO; VERY ELDERLY; YOUNG ADULT;

EID: 84908273768     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S70742     Document Type: Article

References (39)

1. Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468.
2. Birim O, Maat AP, Kappetein AP, van Meerbeeck JP, Damhuis RA, Bogers AJ. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23(1):30–34.
3. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–2447.
4. Lund L, Jacobsen J, Nørgaard M, et al. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study. J Urol. 2009;182(1):35–40; discussion 40.
5. Iversen LH, Nørgaard M, Jacobsen J, Laurberg S, Sørensen HT. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006 – a population-based cohort study. Dis Colon Rectum. 2009;52(1):71–78.
6. Degroot V, Beckerman H, Lankhorst G, Bouter L. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
8. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
9. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
10. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079; discussion 1081–1090.
11. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6): 676–682.
12. Bottle A, Aylin P. Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices. J Clin Epidemiol. 2011;64(12):1426–1433.
13. Sarfati D, Gurney J, Stanley J, et al. Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices. J Clin Epidemiol. 2014;67(5): 586–595.
14. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
15. Sundararajan V, Quan H, Halfon P, et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007;45(12):1210–1215.
16. National Registry [homepage on the Internet]. Available from: http://www.skatteetaten.no/en/Person/National-Registry/?utm_source=1&utm_medium=flyttemelding&utm_campaign=folkeregisteret. Accessed September 6, 2014.
17. Harrell F. Regression coefficients and scoring rules. J Clin Epidemiol. 1996;49(7):819.
18. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. New York: Springer; 2009.
19. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
20. McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, editor. Frontiers in Econometrics (Economic Theory and Mathematical Economics). Amsterdam: Academic; 1974: 105–142.
21. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928–935.
22. Quail JM, Lix LM, Osman BA, Teare GF. Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts. BMC Health Serv Res. 2011;11:146.
23. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103–1120.
24. Hosmer DW, Lemeshow S. Applied Logistic Regression. Hoboken (NJ): Wiley & Sons; 2000.
25. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–172; discussion 207–112.
26. Pencina MJ, D’Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30(1):11–21.
27. Statistics Norway. Statistikkbanken. 2013. Available from: http://www.ssb.no/statistikkbanken. Accessed February 10, 2014.
28. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp; 2013.
29. Gabbe BJ, Harrison JE, Lyons RA, Edwards ER, Cameron PA. Comparison of measures of comorbidity for predicting disability 12-months post-injury. BMC Health Serv Res. 2013;13:30.
30. Kilgore ML, Smith W, Curtis JR, et al. Evaluating comorbidity scores based on health service expenditures. Medicare Medicaid Res Rev. 2012;2:E1–E8.
31. SINTEF. Omfang og Utvikling av Det Selv-betalende Markedet for Private Spesialisthelsetjenester i Norge. Trondheim, Norway: SINTEF; 2010. Available from: http://www.sintef.no/upload/Helse/Rapport%20A15248%20Omfang%20og%20utvikling%20av%20det%20selv-betalende%20markedet.pdf. Accessed August 7, 2014.
32. Norwegian Directory of Health. Samdata Spesialisthelsetjenesten 2012. Oslo: Norwegian Directory of Health; 2013. Available from: http://helsedirektoratet.no/publikasjoner/samdata-2012/Sider/default.aspx. Accessed August 7, 2014.
33. Norwegian University of Science and Technology. Public Health Development: The HUNT Study. Levanger, Norway: HUNT Forskningssenter; 2011. Available from: http://www.ntnu.no/documents/10304/1130562/folkehelse-i-endring-huntrapport-2011.pdf. Accessed February 14, 2014.
34. Norwegian Institute of Public Health. [COPD: facts about chronic obstructive pulmonary disease]. 2013. Available from: http://www.fhi.no/artikler/?id=55604. Accessed February 14, 2014. Norwegian.
35. Cancer Registry of Norway. Cancer in Norway 2011: Cancer Incidence, Mortality, Survival and Prevalence in Norway. Oslo: Cancer Registry of Norway; 2012.
36. Bakken IJ, Gystad SO, Christensen OO, et al. Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway. Tidsskrift Nor Laegeforen. 2012;132(11):1336–1340.
37. Norwegian Directorate of Health. [Activity data for the specialist health-services 2011]. Oslo: Norwegian Directorate of Health; 2011. Available from: http://www.helsedirektoratet.no/publikasjoner/aktivitetsdata-for-somatisk-spesialisthelsetjeneste-2011/Publikasjoner/rapport-somatikk-2011.pdf. Accessed February 14, 2014. Norwegian.
38. Pine M, Jordan HS, Elixhauser A, et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA. 2007;297(1): 71–76.
39. Ghali WA, Quan H, Brant R. Risk adjustment using administrative data: impact of a diagnosis-type indicator. J Gen Intern Med. 2001;16(8): 519–524.